Normal view MARC view ISBD view

Failure of sternal wires depends on the number of turns and plastic deformation: combined experimental and computational approach. [electronic resource]

By:

Capek, Lukas

Contributor(s):

Producer: 20190409Description: 777-782 p. digitalISSN:

1569-9285

Subject(s):

Online resources:

Available from publisher's website

In: Interactive cardiovascular and thoracic surgery vol. 26

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1761 New insights into ovarian cancer pathology.
by Prat, J
1762 Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
by Levy, Douglas E
1763 Mutation screening of RAD51C in high-risk breast and ovarian cancer families.
by Lu, Wenping
1764 BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.
by Otani, Yoko
1765 Rucaparib: a novel PARP inhibitor for
by Colombo, Ilaria
1766 The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations.
by Barnes-Kedar, Inbal
1767 Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.
by Al Hannan, Fatima
1768 Maternal Obesity Alters Placental Cell Cycle Regulators in the First Trimester of Human Pregnancy: New Insights for BRCA1.
by Hoch, Denise
1769 Effectiveness of Neoadjuvant Therapy with Platinum-Based Agents for Patients with BRCA1 and BRCA2 Germline Mutations - A Retrospective Analysis of Breast Cancer Patients Treated at MMCI Brno.
by Holánek, Miloš
1770 Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study.
by West, Allison H
1771 Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers.
by Gaba, Faiza
1772 [A genetic test for breast cancer: curse or blessing?].
by Sauer, H
1773 Genetic susceptibility to breast and ovarian cancer.
by Skolnick, M H
1774 Denaturing gradient gel electrophoresis-based analysis of loss of heterozygosity distinguishes nonobvious, deleterious BRCA1 variants from nonpathogenic polymorphisms.
by de La Hoya, M
1775 Expression of BRCA1 and BRCA2 in normal and neoplastic cells.
by Chodosh, L A
1776 [Prevention of familial breast cancers].
by Nomizu, T
1777 BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite.
by Bernard-Gallon, D J
1778 [BRCA1 and cancer: a new lead].
by Larsen, C J
1779 Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
by Essioux, L
1780 The APCI1307K allele and breast cancer risk.
by Redston, M